Florian Krammer, PhD, discusses whether we will always need COVID-19 booster shots.
Read More
CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission
Why Are Lots of Kids Likely to be Sick This Holiday Season?
How Many Times Will You Get COVID?
Mount Sinai Announces the Formation of CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics, Targeting Pandemic Threats and Diseases of Unmet Medical Need
Nasal vaccines may be the next generation of protection against COVID
The Coronavirus Has Infected More Than Half of Americans, the C.D.C. Reports
Why do some people seem unable to catch COVID? Scientists are looking for answers
Scientific Consortium Established by National Institutes of Health Provides Real-Time Risk Assessment of SARS-CoV-2 Variants on Immune Protection
The Covid Vaccine We Need Now May Not Be a Shot
Easier to produce COVID vaccine shows promise in trials; nasal spray vaccine booster works in mice
